Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (TEVA)
NYSE:TEVA
Teva Pharmaceutical (TEVA) Ownership Overview
0.45% Insiders
7.41% Mutual Funds
30.73% Other Institutional Investors
3.31% ETFs
58.10% Public Companies and
Individual Investors
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail, and individual investors. Approximately 41.44% of the company’s stock is owned by Institutional Investors, 0.45% is owned by Insiders, and 58.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 14, 2025 | Mark Sabag Evp, International Markets Commercial | xxxxxxxxxxxxx | $2886423 |
| Dec 26, 2024 | Roberto Mignone Director | xxxxxxxxxxxxx | $6292000 |
| Aug 13, 2024 | Richard Daniell Exec. Vp, European Commercial | xxxxxxxxxxxxx | $1710724 |
| Aug 13, 2024 | Eric A Hughes Evp, Global R&d And Chief Medical Officer | xxxxxxxxxxxxx | $782692 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $207021 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $220400 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $311976 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1680153 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,413,537 | Institution | 2.31% | 431,333,059 | |
| 25,494,835 | Institution | 2.22% | 416,330,656 | |
| 8,997,400 | Institution | 0.79% | 146,927,542 | |
| 8,491,033 | Institution | 0.74% | 138,658,569 | |
| 8,456,324 | Institution | 0.74% | 138,091,771 | |
| 6,503,485 | Institution | 0.57% | 106,201,910 | |
| 6,225,678 | Institution | 0.54% | 101,665,322 | |
| 4,519,494 | Institution | 0.39% | 73,803,337 | |
| 4,208,741 | Institution | 0.37% | 68,728,741 | |
| 4,065,600 | Institution | 0.35% | 66,391,248 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 25,494,835 | Institution | 2.22% | 416,330,656 | |
| 6,225,678 | Institution | 0.54% | 101,665,322 | |
| 4,519,494 | Institution | 0.39% | 73,803,337 | |
| 4,065,600 | Institution | 0.35% | 66,391,248 | |
| 3,777,689 | Institution | 0.33% | 61,689,661 | |
| 3,602,100 | Institution | 0.31% | 58,822,293 | |
| 3,458,968 | Institution | 0.30% | 56,484,947 | |
| 3,380,686 | Institution | 0.30% | 55,206,602 | |
| 2,979,500 | Institution | 0.26% | 48,655,235 | |
| 2,941,561 | Institution | 0.26% | 48,035,691 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,085,286 | Institution | 0.62% | 116,623,808 | |
| 3,735,103 | Institution | 0.33% | 61,479,795 | |
| 2,550,559 | Institution | 0.22% | 41,982,201 | |
| 1,515,824 | Institution | 0.13% | 24,950,463 | |
| 1,515,824 | Institution | 0.13% | 24,950,463 | |
| 1,442,976 | Institution | 0.13% | 23,751,385 | |
| 1,151,393 | Institution | 0.10% | 18,951,929 | |
| 1,145,656 | Institution | 0.10% | 18,857,498 | |
| 1,043,105 | Institution | 0.09% | 17,169,508 | |
| 904,358 | Institution | 0.08% | 14,885,733 |
FAQ
Who Owns Teva Pharmaceutical (TEVA)?
According to the latest TipRanks data, approximately 30.73% of the company's stock is held by institutional investors, 0.45% is held by insiders, and 58.10% is held by retail investors.
What percentage of Teva Pharmaceutical (TEVA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 30.73% of Teva Pharmaceutical (TEVA) stock is held by institutional investors.
What percentage of Teva Pharmaceutical (TEVA) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.10% of Teva Pharmaceutical (TEVA) stock is held by retail investors.
Who owns the most shares of Teva Pharmaceutical (TEVA)?
iShares owns the most shares of Teva Pharmaceutical (TEVA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.